Press release: Evolution of the Orange group’s Executive
Press release Paris, 31 January 2023 Evolution of the Orange group’s Executive Committee The Orange group announces
Globe Newswire31-01-2023, 14:34
Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal 10-07-2024, 07:00